Sildenafil Citrate Market size is forecast to reach $1.79 billion by 2025, growing at a CAGR of 5.8% during the forecast period 2020-2025. Sildenafil, sold under the brand name Viagra among others, is a medication used to treat erectile dysfunction and pulmonary arterial hypertension. It is unclear if it is effective for treating sexual dysfunction in women. It is taken by mouth or injection into a vein. It belongs to a group of medicines called phosphodiesterase 5 (PDE5) inhibitors. These medicines prevent an enzyme called phosphodiesterase type-5 from working too quickly. Sildenafil has no direct relaxant effect on isolated human corpus cavernosum, but enhances the effect of nitric oxide (NO) by inhibiting phosphodiesterase type 5 (PDE5), which is responsible for degradation of cyclic guanosine monophosphate (cGMP) in the corpus cavernosum. Sildenafil is also used in both men and women to treat the symptoms of pulmonary arterial hypertension. This is a type of high blood pressure that occurs between the heart and the lungs. Growing prevalence of erectile dysfunction owing to harmful lifestyle, rising public awareness about health and sex related problems, rapid product developments by key market players and increasing initiatives by government and NGOs for awareness and treatment campaigns of sex related disorders are driving the market growth in recent years. In addition, major product launches of key players like Lupin Limited are other factors driving the growth of the market. 

Key Takeaways

North America dominated the Sildenafil Citrate Market in the year 2019 owing to growing prevalence of erectile dysfunction, increasing incidences of diabetes and other chronic diseases and changing lifestyle standards. The Sildenafil Citrate Market scope for different regions will be provided in the final report.
Changing lifestyle and habits of majority of population, increased awareness about sex related disorders and technological innovations in development of Sildenafil Citrate and related drugs by key market companies have helped in significant growth of Sildenafil Citrate Market. 
Detailed analysis on the Strength, Weakness and Opportunities of the prominent players operating in the market ` be provided in the Sildenafil Citrate Market report.
Presence of alternatives like Tadalafil and Vardenafil are anticipated to hamper the market growth of the Sildenafil Citrate Industry.

Request for Sample of the Report @ https://www.industryarc.com/pdfdownload.php?id=501922

Geography - Segment Analysis

North America dominated the geography segment of Sildenafil Citrate Market in 2019 with a share of more than 36.71% in 2019, followed by Europe. Rising incidence of diseases like erectile dysfunction and hypertension, presence of key market players in the region and availability of well-established key market players in this region have helped in the growth of Sildenafil Citrate Market infrastructure. Europe held the second place in the geography segment share of the market, owing to presence of robust healthcare infrastructure and increasing favorable government policies for drug market.

Drivers – Sildenafil Citrate Market

Changing lifestyle and habits of majority of population
Increased awareness about sex related disorders

Sildenafil Citrate Market top 10 companies are Aglowmed Pharmaceutical Ltd, Alembic Chemical Work Co. Ltd, Atlas Laboratory Pvt Ltd, H L Healthcare Pvt Ltd, Ind-Swift Limited, Lupin Laboratory Ltd, Ranbaxy Laboratory Ltd, Sun Rise International Lab Ltd, Torrent Pharmaceutical Ltd and Wisdom Pharmaceutical Co., Ltd among others.

About IndustryARC : IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to [email protected] to discuss more about our consulting services.